Accelerating patient access to oncology medicines with multiple indications in Europe
Background: In recent years, innovation in oncology has created new challenges for pricing and reimbursement systems. Oncology medicines with multiple indications face a number of access challenges: (1) the number of assessments and administrative burden; (2) aligning price to different values of th...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
MDPI AG
2021-01-01
|
| Sraith: | Journal of Market Access & Health Policy |
| Ábhair: | |
| Rochtain ar líne: | http://dx.doi.org/10.1080/20016689.2021.1964791 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
